Zerion Pharma A/S — Credit Rating and Financial Key Figures
CVR number: 40169229
Fruebjergvej 3, 2100 København Ø
jdh@zerion.eu
tel: 40968018
www.zerion.eu
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 1 189.90 | 1 932.77 | 3 273.33 | 3 559.96 | 3 452.02 |
| Other operating income | 1 100.00 | 1 680.00 | 67.75 | ||
| Purchases during the financial year | -2 530.33 | -5 179.06 | -8 351.67 | -5 085.67 | -4 803.72 |
| External services | -1 505.62 | -5 148.39 | -5 902.06 | -3 727.68 | -4 482.58 |
| Gross profit | -1 746.05 | -6 714.67 | -10 912.65 | -5 253.39 | -5 834.28 |
| Employee benefit expenses | -1 993.45 | -6 245.37 | -9 538.15 | -6 156.56 | -6 896.75 |
| Total depreciation | -0.66 | - 219.90 | - 441.03 | - 537.20 | - 537.20 |
| EBIT | -3 740.15 | -13 179.94 | -20 891.83 | -11 947.15 | -13 268.23 |
| Other financial income | 5.28 | 3.83 | 2.97 | 0.85 | |
| Other financial expenses | - 271.27 | - 571.13 | -1 241.10 | -1 561.47 | -1 592.57 |
| Net income from associates (fin.) | 12 359.60 | ||||
| Pre-tax profit | -4 011.42 | -13 745.79 | -22 129.10 | -13 505.64 | -2 500.35 |
| Income taxes | 533.77 | 2 611.74 | 3 271.78 | 2 403.75 | 2 280.33 |
| Net earnings | -3 477.65 | -11 134.05 | -18 857.32 | -11 101.89 | - 220.02 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 802.63 | 2 114.47 | 2 945.73 | 2 625.90 | 2 088.70 |
| Tangible assets total | 802.63 | 2 114.47 | 2 945.73 | 2 625.90 | 2 088.70 |
| Other shares and similar rights of ownership | 20.00 | ||||
| Investments total | 158.49 | ||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 595.15 | 595.01 | 818.19 | 492.33 | 184.61 |
| Current amounts owed by group member comp. | 677.86 | ||||
| Prepayments and accrued income | 99.28 | 578.73 | 76.18 | 443.96 | |
| Current other receivables | 888.67 | 1 153.18 | 1 161.76 | 467.83 | 299.90 |
| Current deferred tax assets | 665.41 | 2 611.74 | 3 393.96 | 2 510.00 | 2 350.99 |
| Short term receivables total | 2 248.51 | 4 938.67 | 5 373.91 | 3 546.33 | 3 957.31 |
| Cash and bank deposits | 3 948.61 | 6 644.49 | 4 103.62 | 2 299.97 | 3 466.60 |
| Cash and cash equivalents | 3 948.61 | 6 644.49 | 4 103.62 | 2 299.97 | 3 466.60 |
| Balance sheet total (assets) | 6 999.75 | 13 697.62 | 12 423.25 | 8 472.21 | 9 671.10 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 102.25 | 459.48 | 520.93 | 640.02 | 907.26 |
| Retained earnings | 2 346.30 | 9 807.74 | 8 378.31 | -3 268.64 | -2 945.71 |
| Profit of the financial year | -3 477.65 | -11 134.05 | -18 857.32 | -11 101.89 | - 220.02 |
| Shareholders equity total | -1 029.11 | - 866.83 | -9 958.08 | -13 730.51 | -2 258.47 |
| Non-current loans from credit institutions | 6 198.43 | 10 403.83 | 17 768.02 | 19 196.38 | 8 051.67 |
| Non-current deferred tax liabilities | 175.65 | 175.65 | 181.00 | 187.70 | 193.52 |
| Non-current liabilities total | 6 374.08 | 10 579.47 | 17 949.02 | 19 384.08 | 8 245.19 |
| Current loans from credit institutions | 537.50 | 837.99 | 922.49 | 1 025.36 | |
| Current trade creditors | 760.48 | 2 366.48 | 1 987.24 | 1 536.08 | 1 304.30 |
| Other non-interest bearing current liabilities | 356.80 | 1 618.50 | 1 607.08 | 360.07 | 1 354.73 |
| Current liabilities total | 1 654.78 | 3 984.98 | 4 432.31 | 2 818.64 | 3 684.38 |
| Balance sheet total (liabilities) | 6 999.75 | 13 697.62 | 12 423.25 | 8 472.21 | 9 671.10 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.